Delivery Order SPE2DB25D3008-SPE2DB25FRDKX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,639.67 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation solution (4 gm) on September 26, 2025, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $13,429.73 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under...
- The Defense Logistics Agency awarded a $3,470.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. Performance will be completed at the...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,780.40 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation medication in 4-gram quantities. This non-set-aside, firm fixed price delivery order was competitively awarded and has an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,413.38 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 gram formulation) on September 11, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,844.50 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 gm). This competitively awarded, firm fixed-price contract has a completion date of June 11, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDKXDelivery Order
The Defense Logistics Agency awarded a $2,276.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 grams) on September 26, 2025, with completion expected by September 29, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award supports federal healthcare procurement for the Defense Health Agency and other government healthcare systems requiring respiratory medications for military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/26/25 |